Form 4: ANI Pharma Executive Sells Shares Under 10b5-1 Plan

Meredith Cook, SR. VP, General Counsel & Secretary of ANI Pharmaceuticals, sold 500 shares of common stock for $72.62 per share.

Summary

• Meredith Cook, SR. VP, General Counsel & Secretary of ANI Pharmaceuticals, Inc. (ANIP), reported a sale of common stock.
• The transaction involved the disposition of 500 shares of common stock.
• The shares were sold at a price of $72.62 per share.
• The sale occurred on March 13, 2026.
• Following this transaction, Meredith Cook beneficially owns 79,390 shares of common stock directly.
• The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by the reporting person on September 15, 2025.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is a pre-scheduled transaction under a Rule 10b5-1 plan, which typically indicates personal financial management rather than a signal about the company's future performance.

Negatives

• Meredith Cook, SR. VP, General Counsel & Secretary, sold 500 shares of common stock, which can sometimes be perceived as a lack of confidence, although mitigated by the Rule 10b5-1 plan.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider sales, especially those pre-planned under Rule 10b5-1, are common and typically reflect personal financial planning rather than a change in the company's fundamental outlook or performance. Such transactions are generally viewed as less impactful than unplanned sales.

Stakeholder Impact

• Shareholders: Minimal direct impact due to the small size and pre-planned nature of the transaction.

Key Dates

Recommendation

The sale by a Senior VP is a pre-scheduled transaction under a Rule 10b5-1 plan, indicating personal financial planning rather than a change in company fundamentals or outlook. It is a relatively small transaction compared to the company's market capitalization and the executive's remaining holdings, thus not warranting a change in investment thesis based solely on this filing.

Keywords

ANI Pharmaceuticals, ANIP, Insider Trading, Form 4, Stock Sale, Meredith Cook, Rule 10b5-1